Trypanosoma cruzi in Persons without Serologic Evidence of Disease, Argentina
Oscar A. Salomone* , Ana L. Basquiera*, Adela Sembaj†, Ana M. Aguerri†, María E. Reyes‡, Mirtha Omelianuk*, Ruth A. Fernández†, Julio Enders†, Atilio Palma†, José Moreno Barral†, and Roberto J. Madoery*
Author affiliations: *Hospital Privado Centro Médico de Córdoba, Córdoba, Argentina; †Universidad Nacional de Córdoba, Córdoba, Argentina; ‡Ministerio de Salud de Córdoba, Córdoba, Argentina
Figure. Gel electrophoresis analysis of a polymerase chain reaction (PCR) product corresponding to a highly repetitive 220-bp Trypanosoma cruzi nuclear fragment. 1: molecular weight standards, 2: T . cruzi nuclear 220-bp PCR product, 3 and 4: PCR product from patients blood, 5: PCR negative control (arrows correspond to 220 bp).
The opinions expressed by authors contributing to this journal do not necessarily reflect the opinions of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.